Literature DB >> 32650561

Distinct Microbiota Dysbiosis in Patients with Non-Erosive Reflux Disease and Esophageal Adenocarcinoma.

Jerry Zhou1, Prapti Shrestha1, Zhiguang Qiu2, David G Harman1, Wun-Chung Teoh3, Sam Al-Sohaily1,3, Han Liem4, Ian Turner1,3, Vincent Ho1,3.   

Abstract

Non-erosive reflux disease (NERD) and esophageal adenocarcinoma (EAC) are often regarded as bookends in the gastroesophageal reflux disease spectrum. However, there is limited clinical evidence to support this disease paradigm while the underlying mechanisms of disease progression remain unclear. In this study, we used 16S rRNA sequencing and mass-spectrometer-based proteomics to characterize the esophageal microbiota and host mucosa proteome, respectively. A total of 70 participants from four patient groups (NERD, reflux esophagitis, Barrett's esophagus, and EAC) and a control group were analyzed. Our results showed a unique NERD microbiota composition, distinct to control and other groups. We speculate that an increase in sulfate-reducing Proteobacteria and Bacteroidetes along with hydrogen producer Dorea are associated with a mechanistic role in visceral hypersensitivity. We also observed a distinct EAC microbiota consisting of a high abundance of lactic acid-producing bacteria (Staphylococcus, Lactobacillus, Bifidobacterium, and Streptococcus), which may contribute towards carcinogenesis through dysregulated lactate metabolism. This study suggests the close relationship between esophageal mucosal microbiota and the appearance of pathologies of this organ.

Entities:  

Keywords:  Barrett’s esophagus; esophageal adenocarcinoma; gastroesophageal reflux disease; microbiome; non-erosive reflux disease; proteome; reflux esophagitis

Year:  2020        PMID: 32650561     DOI: 10.3390/jcm9072162

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  6 in total

1.  Roles of 21 Genera of Human Gut Microbiota in Barrett's Esophagus Risk: A Mendelian Randomization Study.

Authors:  Zhao Yang; Rong Yu; Wei Deng; Weihu Wang
Journal:  Front Genet       Date:  2022-06-09       Impact factor: 4.772

2.  Editorial: The Microbiome in Hepatobiliary and Intestinal Disease.

Authors:  Phillipp Hartmann
Journal:  Front Physiol       Date:  2022-04-13       Impact factor: 4.755

3.  Differences in Several Factors in the Development of Erosive Esophagitis Among Patients at Various Stages of Metabolic Syndrome: A Cross-Sectional Study.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Takeshi Kurihara; Miwako Kagawa; Kaizo Kagemoto; Yoshifumi Kida; Tetsu Tomonari; Tatsuya Taniguchi; Koichi Okamoto; Hiroshi Miyamoto; Yasushi Sato; Masahiko Nakasono; Tetsuji Takayama
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-12       Impact factor: 3.168

Review 4.  Challenges in Determining the Role of Microbiome Evolution in Barrett's Esophagus and Progression to Esophageal Adenocarcinoma.

Authors:  Caitlin Guccione; Rena Yadlapati; Shailja Shah; Rob Knight; Kit Curtius
Journal:  Microorganisms       Date:  2021-09-22

Review 5.  Human Microbiota in Esophageal Adenocarcinoma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Implications.

Authors:  Wanyue Dan; Lihua Peng; Bin Yan; Zhengpeng Li; Fei Pan
Journal:  Front Microbiol       Date:  2022-01-14       Impact factor: 5.640

6.  Analysis of gastric microbiota and Helicobacter pylori infection in gastroesophageal reflux disease.

Authors:  Titong Sugihartono; Kartika Afrida Fauzia; Muhammad Miftahussurur; Langgeng Agung Waskito; Purwo Sri Rejeki; Reny I'tishom; Ricky Indra Alfaray; Dalla Doohan; Rizki Amalia; Camilia Metadea Aji Savitri; Yudith Annisa Ayu Rezkitha; Junko Akada; Takashi Matsumoto; Yoshio Yamaoka
Journal:  Gut Pathog       Date:  2022-09-13       Impact factor: 5.324

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.